Jeremy Grenier
Overview
Explore the profile of Jeremy Grenier including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
137
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Denton K, Lei L, Grenier J, Rodionov V, Blackstone C, Li X
Stem Cells
. 2013 Oct;
32(2):414-23.
PMID: 24123785
Human neuronal models of hereditary spastic paraplegias (HSP) that recapitulate disease-specific axonal pathology hold the key to understanding why certain axons degenerate in patients and to developing therapies. SPG4, the...
2.
Amrein L, Shawi M, Grenier J, Aloyz R, Panasci L
Int J Cancer
. 2012 Dec;
133(1):247-52.
PMID: 23238639
BKM120, a pan class I PI3K inhibitor, was cytotoxic in the majority of primary B-chronic lymphocytic leukemia (CLL) lymphocytes, including samples from patients who have a high-risk for poor response...
3.
Davidson D, Grenier J, Martinez-Marignac V, Amrein L, Shawi M, Tokars M, et al.
Invest New Drugs
. 2011 May;
30(4):1736-42.
PMID: 21567185
The purpose of this study was to determine the degree to which the novel DNA-PKcs inhibitor, IC486241 (ICC), synergizes the cytotoxicity of DNA damaging agents in 3 genetically diverse breast...
4.
Davidson D, Coulombe Y, Martinez-Marignac V, Amrein L, Grenier J, Hodkinson K, et al.
Invest New Drugs
. 2011 Jan;
30(3):1248-56.
PMID: 21221710
This study sought to measure the degree of synergy induced by specific small molecule inhibitors of DNA-PK [NU7026 and IC486241 (ICC)], a major component of the non-homologous end-joining (NHEJ) pathway,...